As regulatory requirements regarding the safety,
efficacy and quality of a pharmaceutical product are ever increasing,
PharOS’ Regulatory Affairs experts provides both medical and
registration input at all critical stages during the drug development
process, with the objective of getting to market quickly and efficiently.
PharOS is in contact with consultants throughout Western and Eastern Europe, Canada and the USA.
Our network provides access to information, advice and input with regards to national requirements, guaranteeing the success of multi-national projects such as MRP's and DCP's.
|
